Copaxone Reduces Brain Atrophy,vaccine can help repair damage done to nervous sy

[Guest guest]

Copaxone (Glatiramer Acetate) Reduces Brain Atrophy in Patients with Multiple Sclerosis

KANSAS CITY, MO -- June 8, 2004 -- According to new data published in the April 27 edition of Neurology, Copaxone® (glatiramer acetate injection) significantly reduces brain atrophy in patients living with relapsing-remitting multiple sclerosis (RRMS). As brain atrophy is a sensitive measure of the neurodegenerative component of MS, there is an increasing interest in measuring this phenomenon on more accurate and sensitive MRI techniques.

 

http://www.docguide.com/news/content.nsf/news/8525697700573E1885256EAD0055CA3E?OpenDocument & id=48DDE4A73E09A969852568880078C249 & c=Multiple%20Sclerosis & count=10

 

 

Researcher reports breakthrough on Multiple Sclerosis

Mon Jun 7, 1:36 PM ET

SYDNEY (AFP) - An Australian university researcher announced a breakthrough Monday in efforts to develop a vaccine that can help repair damage done to the nervous system by Multiple Sclerosis (MS).

http://news./news?tmpl=story & u=/afp/20040607/hl_afp/health_ms_vaccine_040607173626